To The Moon

Over the five sessions, more than 50 director interests and substantial shareholdings were filed for close to 30 primary-listed stocks. 

Directors or CEOs reported four acquisitions and no disposals, while substantial shareholders recorded five acquisitions and one disposal.

1. $Aztech Gbl(8AZ.SI)$

On 29 July, Aztech Global Executive Chairman and Chief Executive Officer Michael Mun Hong Yew acquired 100,000 shares at an average purchase price of S$0.715 per share.

Following the market purchase, Mr Mun's total interest in the company increased to 542.8 million shares, equivalent to 70.3% of Aztech Global's issued share capital. The share purchase came a day after Aztech Global reported first-half 2026 net profit of S$9.4 million on revenue of S$151.4 million and declared an interim dividend of S$0.005 per share.

2. $IFAST(AIY.SI)$

On 29 July, Lim Chung Chun, Chairman and Group Chief Executive Officer of iFAST Corporation, acquired 36,200 shares on the market for S$316,326, representing an average purchase price of S$8.74 per share. Following the acquisition, his total interest in the group increased to 60.1 million shares, equivalent to 19.6% of the company's issued shares.

The share purchase followed iFAST Corp's release of its second-quarter results on 24 July, which reported a 35.0% year-on-year increase in net profit to S$29.9 million and a 32.8% increase in assets under administration to a record S$36.1 billion.

3. $Valuetronics(BN2.SI)$

On 24 July, Lion Global Investors acquired 180,600 $Valuetronics(BN2.SI)$ shares at an average price of S$1.12 per share. The purchase increased Lion Global Investors' deemed interest from 19.70 million shares (4.83%) to 19.88 million shares (4.88%). The transaction also lifted the OCBC’s deemed interest from 4.98% to 5.02%, or 20.49 million shares, resulting in the OCBC emerging as a substantial shareholder.

4. $IX Biopharma(42C.SI)$

On 22 July, Lion Global Investors acquired 3.71 million iX Biopharma shares. The purchase increased Lion Global Investors' deemed interest from 49.54 million shares (4.54%) to 53.25 million shares (4.87%). The transaction also lifted the OCBC's deemed interest from 4.71% to 5.04%, or 55.15 million shares, resulting in the OCBC emerging as a substantial shareholder.

5. $Aedge Group(XVG.SI)$

Aedge Group has proposed a placement of 16.67 million new shares at S$0.21 per share to raise gross proceeds of approximately S$3.5 million. The new shares will account for approximately 9.3% of the enlarged share capital. Aedge's previous placement was in May 2025, when it issued 1.95 million new shares at S$0.26 per share to raise gross proceeds of S$507,000.